Related Experiment Video
Updated: May 16, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Radioembolisation for treatment of pediatric hepatocellular carcinoma
Clifford Matthew Hawkins1, Kamlesh Kukreja, James I Geller
1Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. hawkcm@gmail.com
Pediatric Radiology
|December 6, 2012
Abstract:
Transarterial radioembolisation with yttrium-90 (TARE-Y90), a catheter-directed therapy, has been used extensively in adults to treat primary and secondary hepatic malignancies. To our knowledge, the use of this palliative technique has not been described in children. We present two children with unresectable hepatocellular carcinoma (HCC) treated with TARE-Y90.
